Chapter 20

  1. Adle-Biassette H, Bourhy H, Gisselbrecht M, et al. 1996. Rabies encephalitis in a patient with AIDS: a clinicopathological study. Acta Neuropathol 92:415-420.
  2. Aghomo HO, Oduye OO, Rupprecht CE. 1990. The serological response of young dogs to the Flury LEP strain of rabies vaccine. Vet Res Commun 14:415-425.
  3. Aghomo HO, Rupprecht CE. 1990. Antigenic characterization of virus isolates from vaccinated dogs dying of rabies. Trop Anim Health Prod 22:275-280.
  4. Aghomo HO, Rupprecht CE. 1990. Further studies on rabies virus isolated from healthy dogs in Nigeria. Vet Microbiol 22:17-22.
  5. Albas A, Ferrari CI, da Silva LH, et al. 1999. Influence of canine brain decomposition on laboratory diagnosis of rabies. Rev Soc Bras Med Trop 32:19-22.
  6. Allworth A, Murray K, Morgan J. 1996. A human case of encephalitis due to a Lyssavirus recently identified in bats. Commun Dis Intel 25:504.
  7. Anonymous. 1996. Human rabies—California, Georgia, Minnesota, New York, and Wisconsin 2000. MMWR Morb Mortal Wkly Rep 45:1117-1120.
  8. Anonymous. 1996. Rabies, pp 211-213. In OIE manual of standards for diagnostic tests and vaccines, ed 3. Office International des Épizooties, Paris.
  9. Anonymous. 1996. Vets in support of change call for reform of rabies control policy. Vet Rec 139:402-403.
  10. Anonymous. 1997. Update raccoon rabies epizootic—United States, 1996. MMWR Morb Mortal Wkly Rep 45:1117-1120.
  11. Anonymous. 1998. Experts concerned about rabies in bats. J Am Vet Med Assoc 213:190.
  12. Anonymous. 1998. Kennedy review recommends partial replacement of quarantine. Vet Rec 143:374-375.
  13. Anonymous. 1999. Rabies, quarantine and the veterinary profession: the BVA's position. Vet Rec 146:396-397.
  14. Anonymous. 2002. Rabies in a beaver—Florida 2001. MMWR Morb Mortal Wkly Rep 51:481-482.
  15. Anonymous. 2003. Survey on European bat Lyssavirus to be extended. Vet Rec 153:442.
  16. 15a. Anonymous. 2010. USDA Public Health Alert. In response to a recent outbreak of an adapted bat rabies viral variant in terrestrial mammals, skunks in Arizona were trapped, vaccinated, and released. J Am Vet Med Assoc 235:1131.
  17. Arai YT, Kuzmin IV, Kameoka Y, et al. 2003. New Lyssavirus genotype from the lesser mouse-eared bat (Myotis blythi), Kyrghyzstan. Emerg Infect Dis 9:333-337.
  18. Arguin PM. 2000. Survey of rabies preexposure and postexposure prophylaxis among missionary personnel stationed outside the United States. J Travel Med 7:10-14.
  19. Arguin PM, Murray-Lillibridge K, Miranda MEG. 2002. Serologic evidence of Lyssavirus infections among bats, the Philippines. Emerg Infect Dis 8:258- 262.
  20. Arnold RM. 1997. Rabies and quarantine. Vet Rec 141:180.
  21. Arslan A, Saglarn YS, Temur A. 2004. Detection of rabies viral antigens in non-autolysed and autolysed tissue by using an immunoperoxidase technique. Vet Rec 155:550-552.
  22. Arya SC. 1999. Therapeutic failures with rabies vaccine and rabies immunoglobulin. Clin Infect Dis 29:1604-1605.
  23. Aubert MF. 1992. Practical significance of rabies antibodies in cats and dogs. Rev Sci Tech 11:735-760.
  24. Austin CC. 1998. Bats and rabies. J Am Vet Med Assoc 213:1323-1325.
  25. Aylan O, Vos A. 2000. Efficacy of oral rabies vaccine baits in indigenous Turkish dogs. Infect Dis Rev 2:74-77.
  26. Baer GM. 1997. Evaluation of an animal rabies vaccine by use of two types of potency tests. Am J Vet Res 58:837-840.
  27. Bahloul C, Ahmed SB, B’Chir BI, et al. 2003. Post exposure therapy in mice against experimental rabies: a single injection of DNA vaccine is as effective as five injections of cell culture-derived vaccine. Vaccine 22:177-184.
  28. Bahloul C, Taieb D, Kaabi B, et al. 2005. Comparative evaluation of specific ELISA and RFFIT antibody assays in the assessment of dog immunity against rabies. Epidemiol Infect 133:749-757.
  29. Balsamo GA, Ratard RC. 2010. Epidemiology of animal rabies and its practical application to pre- and postexposure prophylaxis, Louisiana, 1988-2007. Vector Borne Zoonotic Dis 10:283.
  30. Barnes HL, Chrisman CL, Farina L, et al. 2003. Clinical evaluation of rabies virus meningoencephalomyelitis in a dog. J Am Anim Hosp Assoc 39:547-550.
  31. Barton LD, Campbell JB. 1988. Measurement of rabies-specific antibodies in carnivores by an enzyme-linked immunosorbent assay. J Wildl Dis 24:246-248.
  32. Bender SC, Bergman DL, Wenning KM, et al. 2009. No adverse effects of simultaneous vaccination with the immunocontraceptive GonaCon and a commercial rabies vaccine on rabies virus neutralizing antibody production in dogs. Vaccine 27:7210-7213.
  33. Bensignor E. 1999. What is your diagnosis? Post-rabies vaccination alopecia. J Small Anim Pract 40:151, 189.
  34. Bingham GM, Budke CM, Slater MR. 2010. Knowledge and perceptions of dog-associated zoonoses: Brazos County Texas, USA. Prev Vet Med 93:211-221.
  35. Bingham J. 2005. Canine rabies ecology in Southern Africa. Emerg Infect Dis 11:1337-1342.
  36. Bingham J, Foggin CM, Wandeler AI, et al. 1999. The epidemiology of rabies in Zimbabwe. 1. Rabies in dogs (Canis familiaris). Onderstepoort J Vet Res 66:1-10.
  37. Bingham J, Foggin CM, Wandeler AI, et al. 1999. The epidemiology of rabies in Zimbabwe. 2. Rabies in jackals (Canis adustus and Canis mesomelas). Onderstepoort J Vet Res 66:11-23.
  38. Bingham J, van der Merwe M. 2002. Distribution of rabies antigen in infected brain material: determining the reliability of different regions of the brain for the rabies fluorescent antibody test. J Virol Meth 101:85-94.
  39. Blancou J, Pastoret PP. 1996. Rabies in cats. Vlaams Diergeneesk Tijdschr 65:232-241.
  40. Blanton JD, Hanlon CA, Rupprecht CE. 2007. Rabies surveillance in the United States during 2006. J Am Vet Med Assoc 231:540-556.
  41. Blanton JD, Krebs JW, Hanlon CA, et al. 2006. Rabies surveillance in the United States during 2005. J Am Vet Med Assoc 229:1897-1911.
  42. Blanton JD, Palmer D, Christian KA, et al. 2008. Rabies surveillance in the United States during 2007. J Am Vet Med Assoc 233:884-897.
  43. 41a. Blanton JD, Palmer D, Rupprecht CE. 2010. Rabies surveillance in the United States during 2009. J Am Vet Med Assoc 237:646-657.
  44. Blanton JD, Robertson K, Palmer D, et al. 2009. Rabies surveillance in the United States during 2008. J Am Vet Med Assoc 235:676-689.
  45. Blasco E, Lambot M, Barrat J, et al. 2001. Kinetics of humoral immune response after rabies VR-G oral vaccination of captive fox cubs (Vulpes vulpes) with or without maternally derived antibodies against the vaccine. Vaccine 19:4805-4815.
  46. Botvinkin AD, Poleschuk EM, Kuzmin IV, et al. 2003. Novel lyssaviruses isolated from bats in Russia. Emerg Infect Dis 9:1623-1625.
  47. Bourhy H, Reynes JM, Dunham EJ, et al. 2008. The origin and phylogeography of dog rabies virus. 2008. J Gen Virol 89:2673-2681.
  48. Bretsky PM, Wilson ML. 2001. Risk factors for exposure to raccoon rabies during an epizootic in Connecticut. Vector Borne Zoonotic Dis 1:211-217.
  49. Briggs D, Hanlon CA. 2007. World Rabies Day: focusing attention on a neglected disease. Vet Rec 161:288-289.
  50. Briggs DJ, Hennessy KJ, Kennedy GA, et al. 1993. Rabies in a vaccinated canine exhibiting generalized demodicosis. J Vet Diagn Invest 5:248-249.
  51. Briggs DJ, Smith JS, Mueller FL, et al. 1998. A comparison of two serological methods for detecting the immune response after rabies vaccination in dogs and cats being exported to rabies-free areas. Biologicals 26:347-355.
  52. Bunn TO. 1991. Canine and feline vaccines, past and present, pp 416-425. In Baer GM (ed): The natural history of rabies. CRC Press, Boca Raton, FL.
  53. Bunn TO. 1991. Cat rabies, pp 379-387. In Baer GM (ed): The natural history of rabies. CRC Press, Boca Raton, FL.
  54. Burki T. 2008. The global fight against rabies. Lancet 372:1135-1136.
  55. Burr P, Duthie S, Haig KT. 2010. Future of PETS. Vet Rec 166:373.
  56. Cadoz M, Strady A, Meignier B, et al. 1992. Immunisation with canarypox virus expressing rabies glycoprotein. Lancet 339:1429-1432.
  57. California Code of Regulations, Title 17, 2650. Canine rabies vaccine advisory committee. Dept of Health Services, Div. of Communicable Dis Control, Infect Dis Branch, Vet Public Health Section, Sacramento.
  58. Campbell JB. 1994. Oral rabies immunization of wildlife and dogs: challenges to the Americas. Curr Top Microbiol Immunol 187:247-266.
  59. Castrodale L, Walker V, Baldwin J, et al. 2008. Rabies in a puppy imported from India to the USA, March 2007. Zoonoses Public Health 55:427-430.
  60. Castrodale L, Westcott M, Dobson J, et al. 2008. Rabies in a three-month-old puppy in south western Alaska. Vet Rec 163:92.
  61. Catchpole M, Thomas L, Morgan D, et al. 2008. Imported rabies in a quarantine centre in the United Kingdom. Eurosurveillance 13(4-6):1-2. www.eurosurveillance.org.
  62. Centers for Disease Control and Prevention. 2007. www.cdc.gov/news/2007/09/canine_rabies.html. Accessed 1/1/9.
  63. Charlton KM, Nadin-Davis S, Casey GA, et al. 1997. The long incubation period in rabies: delayed progression of infection in muscle at the site of exposure. Acta Neuropathol (Berl) 94:73-77.
  64. Cho HC, Lawson KF. 1989. Protection of dogs against death from experimental rabies by postexposure administration of rabies vaccine and hyperimmune globulin. Can J Vet Res 53:434-437.
  65. Chomel B, Chappuis G, Bullon F, et al. 1988. Mass vaccination campaign against rabies: are dogs correctly protected? The Peruvian experience. Rev Infect Dis 10(Suppl):697-702.
  66. Chomel BB. 1993. The modern epidemiological aspects of rabies in the world. Comp Immun Microbiol Infect Dis 16:11-20.
  67. Christian KA, Blanton JD, Auslander M, et al. 2009. Epidemiology of rabies post-exposure prophylaxis—United States of America, 2006-2008. Vaccine 27:7156-7161.
  68. Cima G. 2009. Foxes, skunks spreading bat rabies variant in Arizona (JAVMA News). J Am Vet Med Assoc 235:1130-1131.
  69. Claassen IJTM, Osterhaus ADME, Claassen E. 1995. Antigen detection in vivo after immunization with different presentation forms of rabies virus antigen: involvement of marginal metallophilic macrophages in the uptake of immune-stimulating complexes. Eur J Immunol 25:1446-1452.
  70. Clark KA, Neill SU, Smith JS, et al. 1994. Epizootic canine rabies transmitted by coyotes in south Texas. J Am Vet Med Assoc 204:536-540.
  71. Clark KA, Wilson PJ. 1996. Postexposure rabies prophylaxis and preexposure rabies vaccination failure in domestic animals. J Am Vet Med Assoc 208:1827-1830.
  72. Cleaveland S, Barrat J, Barrat MJ, et al. 1999. A rabies serosurvey of domestic dogs in rural Tanzania: results of a rapid fluorescent focus inhibition test (RFFIT) and a liquid-phase blocking ELISA used in parallel. Epidemiol Infect 123:157-164.
  73. Cleaveland S, Hampson K, Kaare M. 2007. Living with rabies in Africa. Vet Rec 161:293-294.
  74. Cleaveland S, Kaare M, Knobel D, et al. 2006. Canine vaccination-providing broader benefits for disease control. Vet Microbiol 117:43-50.
  75. Cleaveland S, Kaare M, Tiringa P, et al. 2003. A dog rabies vaccination campaign in rural Africa, impact on the incidence of dog rabies and human dog-bite injuries. Vaccine 21:1965-1973.
  76. Cliquet F, Barrat J, Guiot AL, et al. 2008. Efficacy and bait acceptance of vaccinia vectored rabies glycoprotein vaccine in captive foxes (Vulpes vulpes), raccoon dogs (Nyctereutes procyonoides) and dogs (Canis familiaris). Vaccine 26:4627-4638.
  77. Cliquet F, Gurbuxani JP, Pradhan HK, et al. 2007. The safety and efficacy of the oral rabies vaccine SAG2 in Indian stray dogs. Vaccine 25:3409-3418.
  78. Cliquet F, Picard-Meyer E, Barrat J, et al. 2009. Experimental infection of foxes with European bat Lyssaviruses type-1 and 2. BMC Vet Res 5:19-31.
  79. Cliquet F, Verdier Y, Sagné L, et al. 2003. Neutralising antibody titration in 25,000 sera of dogs and cats vaccinated against rabies in France, in the framework of the new regulations that offer an alternative to quarantine. Rev Sci Tech 22 :857-866.
  80. Coleman PG, Dye C. 1996. Immunization coverage required to prevent outbreaks of dog rabies. Vaccine 14:185-186.
  81. Conti LA, Tucker G, Heston S. 1994. Rabies in a dog vaccinated by its owner. J Am Vet Med Assoc 205:1250-1251.
  82. Corn JL, Mendez JR, Catalan EE. 2003. Evaluation of baits for delivery of oral rabies vaccine to dogs in Guatemala. Am J Trop Med Hyg 69:155-158.
  83. Crepin P, Audrey L, Rotivel Y, et al. 1998. Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid. J Clin Microbiol 36:1117-1121.
  84. Dacheux L, Larrous F, Mailles A, et al. 2009. European bat lyssavirus transmission among cats, Europe. Emerg Infect Dis 15:280-284.
  85. Dacheux L, Reynes JM, Buchy P, et al. 2008. A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clin Infect Dis 47:1410-1417
  86. Dato V, Moose C, Rea N, et al. 2009. Human vaccinia infection after exposure to raccoon rabies vaccine bait—Pennsylvania, 2009. MMWR Morb Mortal Wkly Rep 58:1204-1207.
  87. David D, Dveres N, Yakobson BA, et al. 2009. Emergence of dog rabies in the Northern region of Israel. Epidemiol Infect 137:544-548.
  88. David D, Yakobson B, Rotinberg D, et al. 2002. Rabies virus detection by RT-PCR in decomposed naturally infected brains. Vet Microbiol 87:111-118.
  89. De Benedictis P, Mutinelli F, Veggiato C, et al. 2009. Rabies in a vaccinated dog in Italy. Vet Rec 165:216.
  90. De Serres G, Dallaire D, Côte M, et al. 2008. Bat rabies in the United States and Canada from 1950 through 2007: human cases with and without bat contact. Clin Infect Dis 46:1329-1337.
  91. Demattos CA, Demattos CC, Rupprecht CE. 2001. Rhabdoviruses, pp 1245-1277. In Knipe DM, Howley PM (eds): Fields virology, ed 5. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia.
  92. De Serres G, Dallaire F, Côte M, et al. 2008. Bat rabies in the United States and Canada from 1950 through 2007: human cases with and without bat contact. Clin Infect Dis 46:1329-1337.
  93. Desmettre P, Lanquet B, Chappuis G, et al. 1990. Use of vaccinia rabies recombinant for oral vaccination of wildlife. Vet Microbiol 23:227-230.
  94. Dhankhar P, Vaidya SA, Fishbien DB, et al. 2008. Cost effectiveness of rabies post exposure prophylaxis in the United States. Vaccine 26:4251-4255.
  95. Dolivo M, Beretta E, Bonifas, et al. 1978. Ultrastructure and function in sympathetic ganglia isolated from rats infected with pseudorabies virus. Brain Res 140:111-123.
  96. Drenzek CL, Meghan M, Weems MM. 2007. Georgia rabies control manual, ed 5. Georgia Department of Human Resources, Atlanta, p 60.
  97. Dressen DW. 1997. A global review of rabies vaccines for human use. Vaccine 15:801-809.
  98. Dubielzig RR, Hawkins KL, Miller PE. 1993. Myofibroblastic sarcoma originating at the site of rabies vaccination in a cat. J Vet Diagn Invest 5:637-638.
  99. Dürr S, Meltzer MI, Mindekem R, et al. 2008. Owner valuation of rabies vaccination of dogs, Chad. Emerg Infect Dis 14:1650-1652.
  100. Durr S, Mindekem R, Kaninga Y, et al. 2009. Effectiveness of dog rabies vaccination programmes: comparison of owner-charged and free vaccination campaigns. Epidemiol Infect 137:1558-1567.
  101. Eidson M, Matthews SD, Willsey AL, et al. 2005. Rabies virus infection in a pet guinea pig and seven pet rabbits. J Am Vet Med Assoc 227:932-935.
  102. Eng TR, Fishbein DB. 1990. Epidemiologic factors, clinical findings, and vaccination status of rabies in cats and dogs in the United States in 1988. J Am Vet Med Assoc 197:201-209.
  103. Esplin DG, Jaffe MH, McGill LD. 1996. Metastasizing liposarcoma associated with a vaccination site in a cat. Feline Pract 24:20-23.
  104. Esplin DG, McGill L, Meininger AC, et al. 1993. Post vaccination sarcomas in cats. J Am Vet Med Assoc 202:1245-1247.
  105. Esterhuysen JJ, Prehaud C, Thomson GR. 1995. A liquid-phase blocking ELISA for the detection of antibodies to rabies virus. J Virol Methods 51:31-42.
  106. Faber M, Li J, Kean RB, et al. 2009. Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus. Proc Natl Acad Sci USA 106:11300-11305.
  107. Fachin N, Carvalho BA, Cardoso TC. 2005. A comparison of serological methods for detecting the immune response after rabies vaccination in dogs and cows from rabies-endemic areas in Brazil. Intern J Appl Res Vet Med 3:199-206.
  108. Favoretto SR, de Mattos CC, Morais NB, et al. 2001. Rabies in marmosets (Callithrix jacchus), Cearā, Brazil. Emerg Infect Dis 7:1062-1065.
  109. Fearneyhough G, Wilson PJ, Clark KA, et al. 1998. Results of an oral rabies vaccination program for coyotes. J Am Vet Med Assoc 212:498-502.
  110. Fekadu M. 1991. Latency and aborted rabies, pp 192-198. In Baer GM (ed): The natural history of rabies, ed 2. CRC Press, Boca Raton, FL.
  111. Fekadu M, Nesby SL, Shaddock JH, et al. 1996. Immunogenicity, efficacy, and safety of oral rabies vaccine (SAG2) in dogs. Vaccine 14:465-468.
  112. Fehlner-Gardiner C, Muldoon F, Nadin-Davis S, et al. 2008. Laboratory diagnosis of rabies in Canada for calendar year 2006. Can Vet J 49:359-361.
  113. Field H, McCall B, Barrett J. 1999. Australian bat Lyssavirus infection in a captive juvenile black flying fox. Emerg Infect Dis 5:438-440.
  114. Fogelman V, Fischman HR, Horman JT, et al. 1993. Epidemiologic and clinical characteristics of rabies in cats. J Am Vet Med Assoc 202:1829-1838.
  115. Fooks AR, Finnegan C, Johnson N. 2002. Human case of EBL type 2 following exposure to bats in Angus. Scotland Vet Rec 151:679.
  116. Fooks AR, Harkess G, Goddard T, et al. 2008. Rabies virus in a dog imported to the UK from Sri Lanka. Vet Rec 162:598.
  117. Fooks AR, Marston D, Parsons G, et al. 2006. Isolation of EBLV-2 in a Daubenton's bat (Myotis daubentonii) found in Oxfordshire. Vet Rec 157: 534-535.
  118. Fooks AR, McElhinney LM, Marston DA, et al. 2004. Identification of an European bat lyssavirus type 2 in a Daubenton's bat found in Staines, Surrey, UK. Vet Rec 155:434-435.
  119. Foord AJ, Heine HG, Pritchard LI, et al. 2006. Molecular diagnosis of lyssaviruses and sequence comparison of Australian bat lyssavirus samples. Aust Vet J 84:225-230.
  120. Frana TS, Clough NE, Gatewood DM, et al. 2008. Postmarketing surveillance of rabies vaccines for dogs to evaluate safety and efficacy. J Am Vet Med Assoc 232:1000-1002.
  121. Franka R, Wu X, Jackson FR, et al. 2009. Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines. Vaccine 27:7149-7155.
  122. Fraser GC, Hooper PT, Lunt RA, et al. 1996. Encephalitis caused by a Lyssavirus in fruit bats in Australia. Emerging Infect Dis 2:327-331.
  123. French and Belgian Multidisciplinary Investigation Teams. 2008. Identification of a rabid dog illegally introduced from the Republic of the Gambia to Belgium and France. Eur Surveill 13:1-2. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18856.
  124. Fu ZF. 1997. Rabies and rabies research: past, present and future. Vaccine 15:S20-S24.
  125. Gangadhar NL, Gopal T. 1996. Seromonitoring of antibodies in dogs by indirect ELISA following post-bite rabies vaccination. Ind J Anim Sci 66:531-534.
  126. Gibbons RV. 2002. Cryptogenic rabies, bats, and the question of aerosol transmission. Ann Emerg Med 39:528-536.
  127. Gleeson LJ. 1997. Australian bat Lyssavirus—a newly emerged zoonosis? Aust Vet J 75:188.
  128. Goodwin R, Werker DR, Hockin J, et al. 2002. A survey of knowledge, attitudes, and practices of owners with respect to vaccinating their pets against rabies, Ottawa, 2000. Can Commun Dis Rep 28:1-6.
  129. Gould AR, Hyatt AD, Lunt R, et al. 1998. 1998 characterisation of a novel Lyssavirus isolated from Pteropid bats in Australia. Virus Res 54:165-187.
  130. Greene CE, Dreesen DW. 1990. Rabies, pp 365-383. In Greene CE (ed): Infectious diseases of the dog and cat, ed 1. WB Saunders, Philadelphia.
  131. Greene CE, Dreesen DW. 1998. Rabies, pp 114-126. In Greene CE (ed): Infectious diseases of the dog and cat, ed 2. WB Saunders, Philadelphia.
  132. Gumley N. 1999. Rabies revaccination for companion animals: Canadian data. Can Vet J 40:404-407.
  133. 130a. Gummow B, Roefs YA, de Klerk G. 2010. Rabies in South Africa between 1993 and 2005—What has been achieved? J S Afr Vet Assoc 81:16-21.
  134. Gupta PK, Singh RK, Sharma RN, et al. 2001. Preliminary report on a single-tube, non-interrupted reverse transcription-polymerase chain reaction for the detection of rabies virus in brain tissue. Vet Res Commun 25:239-247.
  135. Hagemoser WA, Kluge JP, Hill HT. 1980. Studies on the pathogenesis of pseudorabies in domestic cats following oral inoculation. Can J Comp Med 44:192-202.
  136. Hamir AN, Moser G, Fu ZF, et al. 1995. Immunohistochemical test for rabies: identification of a diagnostically superior monoclonal antibody. Vet Rec 136:295-296.
  137. Hamir AN, Summers BA, Rupprecht CE. 1998. Concurrent rabies and canine distemper encephalitis in a raccoon (Procyon lotor). J Vet Diagn Invest 10:194-196.
  138. Hammami S, Schumacher CL, Cliquet F, et al. 1999. Safety evaluation of the SAG2 rabies virus mutant in Tunisian dogs and several non target species. Vet Res 30:353-362.
  139. Hampson K, Dushoff J, Cleaveland S, et al. 2009. Transmission dynamics and prospects for the elimination of canine rabies. PLoS Biol 7(3):e1000053. doi :10.1371/journal/pbio.1000053.
  140. Hanlon CA, Childs JE, Nettles VF, et al. 1999. Rabies in wildlife. J Am Vet Med Assoc 215:1612-1618.
  141. Hanlon CA, Niezgoda M, Rupprecht CE. 2002. Postexposure prophylaxis for prevention of rabies in dogs. Am J Vet Res 63:1096-1100.
  142. Hanlon CA, Niezgoda M, Shankar V, et al. 1997. A recombinant vaccinia-rabies virus in the immunocompromised host: oral innocuity, progressive parenteral infection, and therapeutics. Vaccine 15:140-148.
  143. Hanlon CA, Olson JG, Clark CJ, et al. 1999. Prevention and education regarding rabies in human beings. J Am Vet Med Assoc 215:1276-1280.
  144. Hanlon CA, Rupprecht CE. 1998. The re-emergence of rabies, pp 59-80. In Scheld WM, Armstrong D, Hughes JM (eds): Emerging infections 1. ASM Press, Washington, DC.
  145. Hanlon CA, Smith JS, Anderson GR, et al. 1999. Laboratory diagnosis of rabies. J Am Vet Med Assoc 215:1444-1446.
  146. Harris SL, Brookes SM, Jones G, et al. 2006. Passive surveillance (1987 to 2004) of United Kingdom bats for European bat lyssaviruses. Vet Rec 159:439-446
  147. Haupt W. 1999. Rabies-risk of exposure and current trends in prevention of human cases. Vaccine 17:1742-1749.
  148. Heath SE, Chomel BB. 1998. Risk factors, prevention and prophylaxis of dog bites for disaster response personnel in the United States. Prehosp Disaster Med 13:58-62.
  149. Heaton PR, Johnstone P, McElhinney LM, et al. 1997. Heminested PCR assay for detection of six genotypes of rabies and rabies-related viruses. J Clin Microbiol 35:2762-2766.
  150. Heaton PR, McElhinney LM, Lowings JP. 1999. Detection and identification of rabies and rabies-related viruses using rapid cycle PCR. J Virol Methods 81:63-69.
  151. Henderson H, Jackson F, Bean K, et al. 2009. Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine. Vaccine 27:7194-7197.
  152. Hemachudha T, Chutivongse S, Wilde H, et al. 1991. Latent rabies. N Engl J Med 324:1890-1891.
  153. Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, et al. 2003. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies. J Infect Dis 188:960-966.
  154. Hendrick MJ, Brooks JJ. 1994. Postvaccinal sarcomas in the cat: histology and immunochemistry. Vet Pathol 31:126-129.
  155. Hendrick MJ, Dunagan CA. 1991. Focal necrotizing granulomatous panniculitis associated with subcutaneous injection of rabies vaccine in cats and dogs: 10 cases (1988-1989). J Am Vet Med Assoc 198:304-305.
  156. Hendrick MJ, Goldschmidt MH. 1991. Do injection site reactions induce fibrosarcomas in cats? J Am Vet Med Assoc 199:968.
  157. Hendrick MJ, Goldschmidt MH, Shofer F, et al. 1992. Postvaccinal sarcomas in the cat: epidemiology and electron probe microanalytical identification of aluminum. Cancer Res 52:5391-5394.
  158. Hendrick MJ, Shofer FS, Goldschmidt MH, et al. 1994. Comparison of fibrosarcomas that developed at vaccination sites and at nonvaccination sites in cats: 239 cases (1991-1992). J Am Vet Med Assoc 205:1425-1429.
  159. Holzmann-Pazgal G, Wanger A, Degaffe G, et al. 2010. Presumptive abortive human rabies. Texas 2009. MMWR Morb Mortal Wkly Rep 59:Feb 26:186-190.
  160. Hooper PT, Fraser GC, Foster RA, et al. 1999. Histopathology and immunochemistry of bats infected by Australian bat Lyssavirus. Aust Vet J 77:595-599.
  161. Hostnik P. 2000. The modification of fluorescent antibody virus neutralization (FAVN) test for the detection of antibodies to rabies virus. J Vet Med B. Infect Dis Vet Public Health 47:423-427.
  162. Hu RL, Fooks AR, Zhang SF, et al. 2008. Inferior rabies vaccine quality and low immunization coverage in dogs (Canis familiaris) in China. Epidemiol Infect 136:1556-1563.
  163. Hu RL, Liu Y, Zhang SF, et al. 2007. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies. Vaccine 25:5301-5307.
  164. Huck RA, Evans DH, Hooper RS, et al. 1969. The isolation of Aujeszky's disease virus from dogs. Vet Rec 81:172.
  165. Ito M, Arai YT, Itou T, et al. 2001. Genetic characterization and geographic distribution of rabies virus isolates in Brazil: identification of two reservoirs, dogs and vampire bats. Virology 284:214-222.
  166. Ito M, Itou T, Sakai T, et al. 2000. Detection of rabies virus RNA isolated from several species of animals in Brazil by RT-PCR. J Vet Med Sci 63:1309-1313.
  167. Jackson AC. 2003. Rabies virus infection: an update. J Neurovirol 9:253-258.
  168. Jackson AC, Rossiter JP. 1997. Apoptosis plays an important role in experimental rabies virus infection. J Virol 71:5603-5607.
  169. Jackson AC, Warrell MJ, Rupprecht CE, et al. 2003. Management of rabies in humans. Clin Infect Dis 36:60-63.
  170. Jackson AC, Wunner WH. 1991. Detection of rabies virus genomic RNA and mRNA in mouse and human brains by in situ hybridization. J Virol 65:2839-2844.
  171. Jacobs FS. 1991. Latent rabies in a cat. J Am Vet Med Assoc 199:677.
  172. Jaijaroensup W, Tantawichien T, Khawplod P, et al. 1999. Postexposure rabies vaccination in patients infected with human immunodeficiency virus. Clin Infect Dis 28:913-914.
  173. Jay MT, Reilly KF, DeBess EE, et al. 1994. Rabies in a vaccinated wolf-dog hybrid. J Am Vet Med Assoc 205:1729-1732.
  174. Jenkins SR, Auslander M, Conti L, et al. 2003. Compendium of Animal Rabies Prevention and Control, 2003. J Am Vet Med Assoc 222:156-161.
  175. Jenkins SR, Auslander M, Conti L, et al. 2004. Compendium of Animal Rabies Prevention and Control, 2004. J Am Vet Med Assoc 224:216-222.
  176. Johnson N, Black C, Smith J, et al. 2003. Rabies emergence among foxes in Turkey. J Wild Dis 39:262-270.
  177. Johnson N, Brookes SM, Fooks AR, et al. 2005. Review of human rabies cases in the UK and in Germany. Vet Rec 26:715.
  178. Johnson N, Cunningham AF, Fooks AR. 2010. The immune response to rabies virus infection and vaccination. Vaccine 28:3896-3901.
  179. Johnson N, Letshwenyo M, Baipoledi EK, et al. 2004. Molecular epidemiology of rabies in Botswana: a comparison between antibody typing and nucleotide sequence phylogeny. Vet Microbiol 101:31-38.
  180. Johnson N, Selden D, Parsons G, et al. 2003. Isolation of a European bat Lyssavirus type 2 from a Daubenton's bat in the United Kingdom. Vet Rec 152:383-387.
  181. 177a. Johnson N, Un H, Fooks AR, et al. 2010. Rabies epidemiology and control in Turkey: past and present. Epidemiol Infect 138:305-312.
  182. Johnson N, Vos A, Freuling C, et al. 2010. Human rabies due to lyssavirus infection of bat origin. Vet Microbiol 142:151-159.
  183. Johnson WB, Walden MB. 1996. Results of a national survey of rabies control procedures. J Am Vet Med Assoc 208:1667-1672.
  184. Jones RD, Kelly L, Fooks, et al. 2005. Quantitative risk assessment of rabies entering Great Britain from North America via cats and dogs. Risk Anal 25:533-542.
  185. Kallel H, Diouani MF, Loukil H, et al. 2006. Immunogenicity and efficacy of an in-house developed cell-culture derived veterinarian rabies vaccine. Vaccine 24:4856-4862.
  186. Kamakawa H, Koiwai M, Satomura S, et al. 2009. Quantitative assessment risk of rabies entering Japan through the importation of dogs and cats from the USA. Epidemiol Infect 137:1149-1154.
  187. Kamolvarin N, Tirawatnpong T, Rattanasiwamoke R, et al. 1993. Diagnosis of rabies by polymerase chain reaction with nested primers. J Infect Dis 167:207-210.
  188. Kasempimolpron S, Saengseesom W, Lumlertdacha, et al. 2000. Detection of rabies virus antigen in dog saliva using a latex agglutination test. J Clin Microbiol 38:3098-3099.
  189. Kass PH, Barnes WG, Spangler WL, et al. 1993. Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. J Am Vet Med Assoc 203:396-405.
  190. Kayali U, Mindekem R, Yemadji N, et al. 2003. Incidence of canine rabies in N'Djamena, Chad. Prev Vet Med 61:227-233.
  191. Kennedy LJ, Lunt M, Barnes A, et al. 2007. Factors influencing the antibody response of dogs vaccinated against rabies. Vaccine 35:8500-8507.
  192. Kim JH, Hwang EK, Sohn HJ, et al. 2005. Epidemiological characteristics of rabies in South Korea from 1993 to 2001. Vet Rec 157:53-56.
  193. Knobel DL. 2003. Seroconversion in captive African wild dogs (Lycaon pictus) following administration of a chicken head bait/SAG-2 oral rabies vaccine combination. Onderstepoort J Vet Res 70:73-77.
  194. Knobel DL, Cleaveland S, Coleman PG, et al. 2005. Re-evaluating the burden of rabies in Africa and Asia. Bull WHO 83:360-368.
  195. 190a. Koop EV, Freuling CM, Kliemt J, et al. 2010. Evaluation of a commercial rabies ELISA as a replacement for serum neutralization assays as part of the pet travel scheme and oral vaccination campaigns of foxes. Berl Munch Tierarztl Wochenschr 123:278-285.
  196. Kobayashi Y, Inoue N, Sato G, et al. 2007. Phylogenetic characterization of rabies virus isolates from Carnivora in Brazil. J Vet Med Sci 69:691-696, 2007.
  197. Krebs JW, Holman RC, Hines U, et al. 1992. Rabies surveillance in the United States during 1991. J Am Vet Med Assoc 201:1836-1848.
  198. Krebs JW, Long-Marin SC, Childs JE. 1998. Causes, costs, and estimates of rabies postexposure prophylaxis treatments in the United States. J Public Health Manag Pract 4:56-62.
  199. Krebs JW, Mandel EJ, Swerdlow DL, et al. 2004. Rabies surveillance in the United States during 2003. J Am Vet Med Assoc 225:1837-1848.
  200. Krebs JW, Mandel EJ, Swerdlow DL, et al. 2005. Rabies surveillance in the United States during 2004. J Am Vet Med Assoc 227:1912-1925.
  201. Krebs JW, Mondul AM, Rupprecht CE, et al. 2001. Rabies surveillance in the United States during 2000. J Am Vet Med Assoc 219:1687-1699.
  202. Krebs JW, Noll HR, Rupprecht CE, et al. 2002. Rabies surveillance in the United States during 2001. J Am Vet Med Assoc 221:1690-1701.
  203. Krebs JW, Rupprecht CE, Childs JE. 2000. Rabies surveillance in the United States during 1999. J Am Vet Med Assoc 217:1799-1811.
  204. Krebs JW, Smith JS, Rupprecht CE, et al. 1998. Rabies surveillance in the United States during 1997. J Am Vet Med Assoc 213:1713-1727.
  205. Krebs JW, Smith JS, Rupprecht CE, et al. 1999. Rabies surveillance in the United States during 1998. J Am Vet Med Assoc 215:1786-1798.
  206. Krebs JW, Strine TW, Childs JE. 1993. Rabies surveillance in the United States during 1992. J Am Vet Med Assoc 203:1718-1731.
  207. Krebs JW, Strine TW, Smith JS, et al. 1994. Rabies surveillance in the United States during 1993. J Am Vet Med Assoc 205:1695-1709.
  208. Krebs JW, Strine TW, Smith JS, et al. 1995. Rabies surveillance in the United States during 1994. J Am Vet Med Assoc 207:1562-1575.
  209. Krebs JW, Strine TW, Smith JS, et al. 1996. Rabies surveillance in the United States during 1995. J Am Vet Med Assoc 209:2031-2044.
  210. Krebs JW, Wheeling JT, Childs JE. 2003. Rabies surveillance in the United states during 2002. J Am Vet Med Assoc 223:1736-1748.
  211. Kristensson K, Dastur DK, Manghani DK, et al. 1996. Rabies interactions between neurons and viruses. A review of the history of Negri inclusion bodies. Neuropathol Appl Neurobiol 22:179-187.
  212. Kuzmin IV, Hughes GJ, Botvinkin AD, et al. 2005. Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition. Virus Res 111:28-43.
  213. Kuzmin IV, Orciari LA, Arai YT, et al. 2003. Bat lyssaviruses (Aravan and Khujand) from Central Asia: phylogenetic relationships according to N, P and G gene sequences. Virus Res 97:65-79.
  214. Kuzmina, IV, Wu X, Tordo N. 2008. Complete genomes of Aravan, Khujand, Irkut and West Caucasian bat viruses, with special attention to the polymerase gene and non-coding regions. Virus Res 136:81-90.
  215. Lakshmanan N, Gore TC, Duncan KL, et al. 2006. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies vaccine. Vet Ther 7:223-231.
  216. La Foy F et al. 1994. Vaccination against rabies: construction and characterization of SAG2, a stable avirulent derivative of SAD Bern. Vaccine 12:317-320
  217. Last RD, Jardine JE, Smit MME, et al. 1994. Application of immunoperoxidase techniques to formalin-fixed brain tissue for the diagnosis of rabies in southern Africa. Onderstepoort J Vet Res 61:183-187.
  218. Lawson KF, Bachmann P. 2001. Stability of attenuated live virus rabies vaccine in baits targeted to wild foxes under operational conditions. Can Vet J 42:368-374.
  219. Lee JH, Lee MJ, Lee JB, et al. 2001. Review of canine rabies prevalence under two different vaccination programmes in Korea. Vet Rec 148:511-512.
  220. Lembo T, Hampson K, Kaare MT, et al. 2010. The feasibility of canine rabies elimination in Africa: Dispelling doubts with data. PLOS Neglect Trop Dis 4(2):e626.
  221. Lembo T, Haydon DT, Velasco-Villa A, et al. 2007. Molecular epidemiology identifies only a single rabies virus variant circulating in complex carnivore communities of the Serengeti. Proc R Soc B 274: 2123-2130.
  222. Lembo T, Niezgoda M, Velasco-Villa A, et al. 2006. Evaluation of a direct, rapid immunohistochemical test for rabies diagnosis. Emerg Infect Dis 12:310-313.
  223. Lemos-Filho L, Fries B. 2006. An encounter with rabies in New York City. Clin Infect Dis 43:1492-1493.
  224. Leslie MJ, Jenkins SR, Auslander M, et al. 2001. Committee thinks rabies postexposure protocol raises public health concerns. J Am Vet Med Assoc 281:1413.
  225. Leslie MJ, Messenger S, Rohde RE, et al. 2006. Bat-associated rabies virus in skunks. Emerg Infect Dis 12:1274-1277.
  226. Lewis VJ, Thacker WL. 1974. Limitations of deteriorated tissue for rabies diagnosis. Health Lab Sci 11:8-12.
  227. Lodmell DL, Ewalt LC, Parnell MJ, et al. 2006. One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus. Vaccine 24:412-416.
  228. Lodmell DL, Parnell MJ, Weyhrich JT, et al. 2003. Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody. Vaccine 21:3998-4002.
  229. Lodmell DL, Ray NB, Parnell MJ, et al. 1998. DNA immunization protects nonhuman primates against rabies virus. Nat Med 4:949-952.
  230. Lontai I. 1997. The current state of rabies prevention in Europe. Vaccine 15:S16-S19.
  231. Lopez T. 1997. Quarantine changes take effect in Hawaii. J Am Vet Med Assoc 211:817-819.
  232. Mangieri N, Campbell C, Fratz G, et al. 2008. Rabies in a dog imported from Iraq—New Jersey, June 2008. MMWR Morb Mortal Wkly Rep 57(39):1076-1078.
  233. Manickam R, Basheer MD, Jayakumar R. 2008. Post-exposure prophylaxis (PEP) of rabies-infected Indian street dogs. Vaccine 26:6564-6568.
  234. Manning SE, Rupprecht RE, Fishbein D, et al. 2008. Human rabies prevention—United States, 2008. Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 57(RR-3):1-27.
  235. Manning SE, Rupprecht CE, Fishbein D. 2008. Human rabies-prevention United States, 2008. Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 57(RR-3):1-27.
  236. Mansfield KL, Burr RD, Snodgrass DR, et al. 2004. Factors affecting the serological response of dogs and cats to rabies vaccination. Vet Rec 154:423-426.
  237. McColl KA, Chamberlain T, Lunt RA, et al. 2007. Susceptibility of domestic dogs and cats to Australian bat lyssavirus (ABLV). Vet Microbiol 123:15-25.
  238. McColl KA, Gould AR, Selleck PW, et al. 1993. Polymerase chain reaction and other laboratory techniques in the diagnosis of long incubation rabies in Australia. Aust Vet J 70:84-89.
  239. McGuill MW, Kreindel SM, De Maria A, et al. 1998. Human contact with bait containing vaccine for control of rabies in wildlife. J Am Vet Med Assoc 213:1413-1417.
  240. McQuiston JH, Wilson T, Harris S, et al. 2008. Importation of dogs into the United States: risks from rabies and other zoonotic diseases. Zoonoses Public Health 55Z:421-426.
  241. McQuiston JH, Yager PA, Smith JS, et al. 2001. Epidemiologic characteristics of rabies virus variants in dogs and cats in the United States, 1999. J Am Vet Med Assoc 218:1939-1942.
  242. Mebatsion T, Sillero-Zubiri C, Gottelli D, et al. 1992. Detection of rabies antibody by ELISA and RFFIT in unvaccinated dogs and in the endangered simian jackal (Canis simensis) of Ethiopia. J Vet Med B 39:233-235.
  243. Meehan SK. 1995. Rabies epizootic in coyotes combated with an oral vaccination program. J Am Vet Med Assoc 206:1097-1099.
  244. Meltzer MI, Rupprecht CE. 1998. A review of the economics of the prevention and control of rabies. Part 2: rabies in dogs, livestock and wildlife. Pharmacoeconomics 14:481-498.
  245. Messenger SL, Smith JS, Orciari LA, et al. 2003. Emerging pattern of rabies deaths and increased viral infectivity. Emerg Infect Dis 9:151-154.
  246. Messenger SL, Smith JS, Rupprecht CE. 2002. Emerging epidemiology of bat-associated cryptic cases of rabies in humans in the United States. Clin Infect Dis 35:738-746.
  247. Minke JM, Bouvet J, Ciquet E, et al. 2009. Comparison of antibody responses after vaccination with two inactivated rabies vaccines. Vet Microbiol 133:283-286.
  248. Mitka M. 2010. Streamlining rabies prophylaxis. JAMA 303:1586.
  249. Montano Hirase JA, Bourhy H, Sureau P. 1991. Retrobulbar route for brain specimen collection for rabies diagnosis. Vet Rec 129:291-292.
  250. Moore DA, Sischo WM, Hunter A. 2000. Animal bite epidemiology and surveillance for rabies postexposure prophylaxis. J Am Vet Med Assoc 217:190-194.
  251. Moore GE, Ward MP, Kulldorff M et al. 2005. A space-time cluster of adverse events associated with canine rabies vaccine. Vaccine 23 :5557-5562.
  252. Moore SM, Ricke TA, Davis RD, et al. 2005. The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays. Biologicals 33:269-276.
  253. Morimoto K, Patel M, Corisedo S, et al. 1996. Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America. Proc Natl Acad Sci USA 93:7949-7952.
  254. Müller TF, Schuster P, Vos AC, et al. 2001. Effect of maternal immunity on the immune response to oral vaccination against rabies in young foxes. Am J Vet Res 62:1154-1158.
  255. Murray KO, Arguin PM. 2000. Decision-based evaluation of recommendations for preexposure rabies vaccination. J Am Vet Med Assoc 216:188-191.
  256. Murray KO, Holmes KC, Hanlon CA. 2009. Rabies in vaccinated dogs and cats in the United States, 1997-2001. J Am Vet Med Assoc 235:691-695.
  257. Nagaraj T, Vasanth JP, Desai A, et al. 2006. Ante mortem diagnosis of human rabies using saliva samples: comparison of real time and conventional RT-PCR techniques. J Clin Virol 36:17-23.
  258. 252a. Napp S, Casas M, Moset S, et al. 2010. Quantitative risk assessment model of canine rabies introduction: application to the risk to the European Union from Morocco. Epidemiol Infect 138:1569-1580.
  259. Nathwani D, McIntyre PG, White K, et al. 2003. Fatal human rabies caused by European bat Lyssavirus type 2a infection in Scotland. Clin Infect Dis 37:598-601.
  260. National Association of State Public Health Veterinarians. 2008. Compendium of animal rabies prevention and control 2008. MMWR Morb Mortal Wkly Rep 57(RR-2):1-9 and J Am Vet Med Assoc 232:1478-1486.
  261. Nelson RS, Mshar PA, Carter ML, et al. 1998. Public awareness of rabies and compliance with pet vaccination laws in Connecticut, 1993. J Am Vet Med Assoc 212:1552-1555.
  262. 255a. Nichols PR, Morris DO, Beale KM. 1999. A retrospective study of canine and feline cutaneous vasculitis. Vet Dermatol 12:255-264.
  263. Nicholson KG. 1990. Modern vaccines—rabies. Lancet 335:1201-1205.
  264. Noah DL, Drenzek CL, Smith JS, et al. 1998. Epidemiology of human rabies in the United States, 1980-1996. Ann Intern Med 128:922-930.
  265. Noah DL, Smith MG, Gotthardt JC, et al. 1996. Mass human exposure to rabies in New Hampshire: exposures, treatment and cost. Am J Public Health 86:1149-1151.
  266. Nunan CP, Tinline RR, Honig JM, et al. 2002. Postexposure treatment and animal rabies, Ontario, 1958-2000. Emerg Infect Dis 8:214-217.
  267. Odontsetseg N, Uuganbayar D, Tserendori SH, et al. 2009. Animal and human rabies in Mongolia. Rev Sci Tech 28:995-1003.
  268. Oertli EH, Wilson PJ, Hunt PR, et al. 2009. Epidemiology of rabies skunks in Texas. J Am Vet Med Assoc 234:616-620.
  269. Ogawa T, Gamoh K, Aoki H, et al. 2008. Validation and standardization of virus neutralizing test using indirect immunoperoxidase technique for the quantification of antibodies to rabies virus. Zoonoses Public Health 55:323-327.
  270. Okoh AEJ. 2000. Antigenic characterization of rabies virus isolates from vaccinated dogs in Plateau State, Nigeria. Vet Res Commun 24:203-211.
  271. Oliveira R, Takaoka N, Brandao P, et al. 2006. Postmortem confirmation of human rabies source. Emerg Infect Dis 12:867-869.
  272. Orciari LA, Niezgoda M, Hanlon CA, et al. 2001. Rapid clearance of SAG-2 rabies virus from dogs after oral vaccination. Vaccine 19:4511-4518.
  273. Osorio JE, Tomlinson CC, Frank RS, et al. 1999. Immunization of dogs and cats with a DNA vaccine against rabies virus. Vaccine 17:1109-1116.
  274. Overall KL. 2000. Rabies vaccine labeling and the wolf hybrid. J Am Vet Med Assoc 216:20.
  275. Páez A, Nuñez C, Garcia C, et al. 2003. Molecular epidemiology of rabies epizootics in Columbia evidence for human and dog rabies associated with bats. J Gen Virol 84:795-802.
  276. Palomba E, Tovo PA. 1999. Post exposure rabies vaccination in patients infected with human immunodeficiency virus. Clin Infect Dis 28:913-914.
  277. Pape WJ, Fitzsimmons TD, Hoffman RE. 1999. Risk for rabies transmission from encounters with bats, Colorado, 1977-1996. Emerg Infect Dis 5:433-436.
  278. Parry J. 2000. Rabies vaccinations. Vet Rec 146:591.
  279. Parviz S, Luby S, Wilde H. 1998. Post exposure treatment of rabies in Pakistan. Clin Infect Dis 27:751-756.
  280. Pastoret PP, Brochier B. 1998. Epidemiology and elimination of rabies in Western Europe. Vet J 156:85-90.
  281. Patronek GJ. 1998. Free-roaming and feral cats-their impact on wildlife and human beings. J Am Vet Med Assoc 212:218-226.
  282. Perrin P, Jacob Y, Aguilar-Setien A, et al. 1999. Immunization of dogs with a DNA vaccine induces protection against rabies virus. Vaccine 18:479-486.
  283. Plotkin SA. 2000. Rabies. Clin Infect Dis 30:4-12.
  284. Poulter D. 1996. Rabies and quarantine. Vet Rec 139:475.
  285. 277a. Ramon ME, Slater MR, Ward MP. 2010. Companion animal knowledge, attachment and pet care and their associations with household demographics for residents of a rural Texas town. Prev Vet Med 94:251-263.
  286. Randall DA, Williams SD, Nagaraj T, et al. 2004. Rabies in endangered Ethiopian wolves. Emerg Infect Dis 10:2214-2217.
  287. Reece JF. 2007. Rabies in India: an ABC approach to combating the disease in street dogs. Vet Rec 161:292-293.
  288. Reece JF, Chawla SK. 2006. Control of rabies in Jaipur, India, by the sterilization and vaccination of neighbourhood dogs. Vet Rec 159:379-383.
  289. Robbins AH, Borden MD, Windmiller BS. 1998. Prevention of the spread of rabies to wildlife by oral vaccination of raccoons in Massachusetts. J Am Vet Med Assoc 213:1407-1412.
  290. Roberts DH. 1999. Quarantine and rabies. Vet Rec 145:531-532.
  291. Robinson LE, Fishbein DB. 1991. Rabies. Semin Vet Med Surg (Small Anim) 6:203-211.
  292. Rohde RE, Neill SU, Clark KA, et al. 1997. Molecular epidemiology of rabies epizootics in Texas. Clin Diagn Virol 8:209-217.
  293. Ronsholt L, Sorensen KJ, Bruschke CIM, et al. 1998. Clinical silent rabies infection in (zoo) bats. Vet Rec 142:519-520.
  294. Roseveare CW, Goolsby WD, Foppa IM. 2009. Potential and actual terrestrial rabies exposures in people and domestic animals, Upstate South Carolina, 1994-2004: a surveillance study. BMC Public Health 9:65.
  295. Rotz LD, Hensley JA, Rupprecht CE, et al. 1998. Large-scale human exposure to rabid or presumed rabid animals in the United States: 22 cases (1990-1996). J Am Vet Med Assoc 212:1198-1200.
  296. Rudd RT, Trimarchi CV. 1989. Development and evaluation of an in vitro virus isolation procedure as a replacement for the mouse inoculation test in rabies diagnosis. J Clin Microbiol 27:2522-2528.
  297. Rudmann DG, Vanalstine WG, Doddy F, et al. 1996. Pulmonary and mediastinal metastases of a vaccination site sarcoma in a cat. Vet Pathol 33:466-469.
  298. 289a. Ruiz M, Chavez CB. 2010. Rabies in Latin America. Neurol Res 32:272-277.
  299. Rupprecht CE. 1991. Comments on latent rabies in a cat. J Am Vet Med Assoc 199:1686-1687.
  300. Rupprecht CE. 2007. Veterinary responsibility in management of "the incurable wound." Vet Rec 161:290-291.
  301. Rupprecht CE, Blass L, Smith K, et al. 2001. Human infection due to recombinant vaccina-rabies glycoprotein virus. N Eng J Med 345:582-586.
  302. Rupprecht CE, Briggs D, Brown CM, et al. 2009. Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals. Vaccine 27:7141-7148.
  303. Rupprecht CE, Briggs D, Brown CM, et al. 2010. Prophylaxis to prevent human rabies : Recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 59:1-9.
  304. Rupprecht CE, Childs JE. 1996. Feline rabies. Feline Pract 24:15-19.
  305. Rupprecht CE, Hanlon CA, Blanton J, et al. 2005. Oral vaccination of dogs with recombinant rabies virus vaccines. Virus Res 111:101-105.
  306. Rupprecht CE, Shaddock JS, Sanderlin DW, et al. 1998. Oral rabies vaccination of dogs. Israel J Vet Med 34:228-239.
  307. Rupprecht CE, Smith JS, Krebs JW, et al. 1997. Molecular epidemiology of rabies in the United States: reemergence of a classical neurotropic agent. J Neurovirol 3(Suppl 1):S52-S53.
  308. Rupprecht CE, Willoughby R, Slate D. 2006. Current and future trends in the prevention, treatment and control of rabies. Expert Rev Anti Infective Ther 4:1021-1038.
  309. 299a. Sabeta C, Blumberg L, Miyen J, et al 2010. Mokola virus involved in a human contact (South Africa). FEMS Immunol Med Microbiol 58:85-90.
  310. Saengseesom W, Mitmoonpitak C, Kasempimolporn S, et al. 2007. Real-time PCR analysis of dog cerebrospinal fluid and saliva samples for ante-mortem diagnosis of rabies. Southeast Asian J Trop Med Public Health 38:53-57.
  311. Sage G, Khawplod P, Wilde H, et al. 1993. Immune response to rabies vaccine in Alaskan dogs: failure to achieve a consistently protective vaccine response. Trans R Soc Trop Med Hyg 87:593-595.
  312. Schaefer R, Batista HBR, Franco AC, et al. 2005. Studies on antigenic and genomic properties of Brazilian rabies virus isolates. Vet Microbiol 107:161-170.
  313. Schaefer R, Caladas E, Schmidt E, et al. 2002. First case of cat rabies in southern Brazil. Vet Rec 150:216-217.
  314. Schaftenaar W, Ronsholt L. 1998. Clinically silent rabies infection in (zoo) bats. Vet Rec 143:86-87.
  315. Schnell MJ, McGettigan JP, Wirblich C, et al. 2010. The cell biology of rabies virus: using stealth to reach the brain. Nat Rev Microbiol 8:51-61.
  316. Schultze AE, Frank LA, Hahn KA. 1997. Repeated physical and cytologic characterizations of subcutaneous postvaccinal reactions in cats. Am J Vet Res 58:719-724.
  317. Schwiff SA, Kirkpatrick KN, Sterner RT. 2006. Economic evaluation of an oral rabies vaccination program for control of a domestic dog-coyote rabies epizootic: 1995-2006. J Am Vet Med Assoc 233:1736-1741.
  318. Seghaier C, Cliquet F, Hammami S, et al. 1999. Rabies mass vaccination campaigns in Tunisia: are vaccinated dogs correctly immunized? Am J Trop Med Hyg 61:879-884.
  319. Shimazaki Y, Inoue S, Takahashi C, et al. 2003. Immune response to Japanese rabies vaccine in domestic dogs. J Vet Med B Infect Dis Public Health 50:95-98.
  320. Sidwa TJ, Wilson PJ, Moore GM, et al. 2005. Evaluation of oral rabies vaccination programs for control of rabies epizootics in coyotes and gray foxes: 1995-2003. J Am Vet Med Assoc 227:785-792.
  321. Sitprija V, Sriaroon C, Lumlertdaecha B, et al. 2003. Does contact with urine and blood from a rabid dog represent a rabies risk? Clin Infect Dis 37:1399-1400.
  322. Skully RE, Mark EJ, McNeely WF, et al. 1998. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 21-1998. A 32-year-old woman with pharyngeal spasms and paresthesias after a dog bite. N Engl J Med 339:105-112.
  323. Smith JS. 1996. New aspects of rabies with emphasis in epidemiology, diagnosis, and prevention of the disease in the United States. Clin Microbiol Rev 9:166-176.
  324. Smith JS, Orciari LA, Yager PA, et al. 1992. Epidemiologic and historical relationships among 87 rabies virus isolates as determined by limited sequence analysis. J Infect Dis 166:296-307.
  325. Smith JS, Seidel HD. 1993. Rabies: a new look at an old disease. Prog Med Virol 40:82-106.
  326. Strady A, Lang J, Lienard M, et al. 1998. Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy. J Infect Dis 177:1290-1295.
  327. Steffens I, Ekdahl K. 2008. Rabies—a recurrent danger to European countries from dogs introduced from endemic countries. Euro Surveill 13(4-6):1-2.
  328. Sterner RT, Meltzer MI, Shwiff SA, et al. 2009. Tactics and economics of wildlife oral rabies vaccination, Canada and the United States. Emerg Infect Dis 15:1176-1184.
  329. Suja MS, Mahadevan A, Nadhusudhana SN, et al. 2009. Neuroanatomical mapping of rabies nucleocapsid viral antigen distribution and apoptosis in pathogenesis in street dog rabies—an immunohistochemical study. Clin Neuropathol 28:113-124.
  330. Suliova J, Benisek Z, Svrcek S, et al. 1997. The effectiveness of inactivated, purified and concentrated experimental rabies vaccine for veterinary use: immunogenic activity. Vet Med (Praha) 42:51-56.
  331. Suzuki K, Pecoraro MR, Loza A, et al. 2008. Antibody seroprevalences against rabies in dogs vaccinated under field conditions in Bolivia. Trop Anim Health Prod 40:607-613.
  332. Takahashi-Omoe H, Omoe K, Okabe N. 2008. Regulatory systems for prevention and control of rabies, Japan. Emerg Infect Dis 14:1368-1374.
  333. Talbi C, Holmes EC, de Benedictis P, et al. 2009. Evolutionary history and dynamics of dog rabies virus in western and central Africa. J Gen Virol 90:783-791.
  334. Tang X, Luo M, Zhang S, et al. 2005. Pivotal role of dogs in rabies transmission, China. Emerg Infect Dis 11:1970-1972.
  335. Tantawichien T, Tantawichien T, Supit C, et al. 2001. Three-year experience with 4-site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis. Clin Infect Dis 33:2085-2087.
  336. Taylor J, Trimarchi C, Weinberg R, et al. 1991. Efficacy studies on a canarypox-rabies recombinant virus. Vaccine 9:190-193.
  337. Tepsumethalanon V, Lumiertdacha B, Mitmoonpitak C, et al. 1997. Fluorescent antibody test for rabies: prospective study of 8987 brains. Clin Infect Dis 25:1459-1461.
  338. Tepsumethanon V, Lumlertdacha B, Mitmoonpitak C, et al. 2004. Survival of naturally infected rabid dogs and cats. Clin Infect Dis 39:278-280.
  339. Tepsumethanon W, Polsuwan C, Lumlertdaecha B, et al. 1991. Immune response to rabies vaccination in Thai dogs: a preliminary report. Vaccine 9:627-630.
  340. Tesoro-Cruz E, Rafael Calderón-Rodríguez R, Rafael Hernández-González R, et al. 2008. Intradermal DNA vaccination in ear pinnae is an efficient route to protect cats against rabies virus. Vet Res 39:16.
  341. Thomas CL. 1997. Some thoughts on quarantine changes in Hawaii. J Am Vet Med Assoc 211:1229.
  342. Thompson GK. 1999. Veterinary surgeon's guide to Australian bat Lyssavirus. Aust Vet J 77:710-712.
  343. Tierkel ES. 1973. Shipment of specimens and techniques for preparation of animal tissue, pp 29-40. In Kaplan MM, Kaprowski H (eds): Laboratory techniques in rabies (Monograph Series no 23). World Health Organization, Geneva.
  344. Tims T, Briggs DJ, Davis RD, et al. 2000. Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies. Vaccine 18:2804-2807.
  345. Tjørnehøj K, Rønsholt L, Fooks AR. 2004. Antibodies to EBLV-1 in a domestic cat in Denmark. Vet Rec 155:571-572.
  346. Trevejo RT. 2000. Rabies preexposure vaccination among veterinarians and at risk staff. J Am Vet Med Assoc 217:1647-1650.
  347. Tribe GW, Kerr MG. 2000. Rabies antibody and the Pet Travel Scheme. Vet Rec 147:427.
  348. Uhaa IJ, Mandel EJ, Whiteway R, et al. 1992. Rabies surveillance in the United States during 1990. J Am Vet Med Assoc 200:920-929.
  349. Van de Zande S, Kaashoek M, Hesselink W, et al. 2009. Comments: Comparison of antibody responses after vaccination with two inactivated rabies vaccines. Vet Microbiol 138:202-203.
  350. Velasco-Villa A, Reeder SA, Orciari LA, et al. 2008. Enzootic rabies elimination from dogs and re-emergence in wild terrestrial carnivores, United States. Emerg Infect Dis 14:1849-1854.
  351. Vishawapoka U, Hemachudha T, Tepsumethanon W, et al. 1988. Detection of rabies antigen in canine parotid glands by dot-blot technique. Lancet 1:881.
  352. Vitale C, Gross M. 1999. Vaccine-induced ischemic dermatopathy in the dog. Vet Dermatol 10:131-142.
  353. Vodopija R, Lafont M, Bakliaic Z, et al. 1997. Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine. Vaccine 15:571-574.
  354. Wacharapluesadee S, Hemachudha T. 2001. Nucleic acid sequence based amplification in the rapid diagnosis of rabies. Lancet 358:892-893.
  355. Wacharapluesadee S, Hemachudha T. 2002. Urine samples for rabies RNA detection in the diagnosis of rabies in humans. Clin Infect Dis 34:874-875.
  356. Wacharapluesadee S, Hemachudha T. 2010. Ante- and post-mortem diagnosis of rabies using nucleic acid–amplification tests. Exp Rev Mol Diagn 10:207-218.
  357. Wacharapluesadee S, Phumesin P, Lumlertdaecha B, et al. 2003. Diagnosis of rabies by use of brain tissue dried in filter paper. Clin Infect Dis 36:674-675.
  358. Wacharapluesadee S, Sutipanya J, Damrongwatanapokin S, et al. 2008. Development of a TaqMan real-time RT-PCR assay for the detection of rabies virus. J Virol Meth 151:317-320.
  359. Wang X, Werner BG, Konomi R, et al. 2009. Animal rabies in Massachusetts, 1986-2006. J Wildl Dis 45 :376-387.
  360. Wang Y, Xiang Z, Pasquini S, et al. 1997. Immune response to neonatal genetic immunization. Virology 228:278-284.
  361. Warner CK, Whitfield SG, Fekadu M, et al. 1997. Procedures for reproducible detection of rabies virus-antigen messenger-RNA and genome in-situ in formalin-fixed tissues. J Virol Methods 67:5-12.
  362. 351a. Warrell M. 2010. Rabies and African bat lyssavirus encephalitis and its prevention. Int J Antimicrob Agents 36(Suppl):S547-S552.
  363. Warrell MJ, Warrell DA. 2003. Intradermal regimens for rabies postexposure prophylaxis: more confusion. Clin Infect Dis 35:213-214.
  364. Warrilow D, Harrower B, Smith IL, et al. 2003. Public health surveillance for Australian bat Lyssavirus in Queensland, Australia, 2000-2001. Emerg Infect Dis 9:262-264.
  365. Warshawsky B, Desai S. 2010. Exposure to bats: updated recommendations. Can Med Assoc J 182:60.
  366. Weiland F, Cox JH, Meyer S, et al. 1992. Rabies virus neuritic paralysis: immunopathogenesis of nonfatal paralytic rabies. J Virol 66:5096-5099.
  367. Weissinger MD, Theimer TC, Bergman DL, et al. 2009. Nightly and seasonal movements, seasonal home range, and focal location photo-monitoring of urban striped skunks (Mephitis mephitis): implications for rabies transmission. J Wildl Dis 45:388-397.
  368. Weng HY, Wu PI, Yang PC, et al. 2010. A quantitative risk assessment model to evaluate effective border control measures for rabies prevention. Vet Res 41:11.
  369. Weyer J, Rupprecht CE, Nel LH. 2009. Poxvirus-vectored vaccines for rabies—a review. Vaccine 27:7098-7201.
  370. Whitby J. 1996. Rabies diagnosis and the central veterinary laboratory. Vet Rec 139:433.
  371. Whitby JE, Heaton PR, Black EM, et al. 2000. First isolation of a rabies related virus from a Daubenton's bat in the United Kingdom. Vet Rec 147:385-388.
  372. Wilde H. 2005. Fox rabies in India. Clin Infect Dis 40:614-615.
  373. Wilde H, Khawplod P, Hemachudha T, et al. 2002. Postexposure treatment of rabies infection: can it be done without immunoglobulin. Clin Infect Dis 34:477-480.
  374. Willoughby RE, Tieves KS, Hoffman GM, et al. 2005. Survival after treatment of rabies with induction of coma. N Engl J Med 352:2508-2514.
  375. Wilson PJ, Clark KA. 2001. Postexposure rabies prophylaxis protocol for domestic animals and epidemiologic characteristics of rabies vaccination failures in Texas: 1995-1999. J Am Vet Med Assoc 218:522-524.
  376. Woldehiwet Z. 2002. Rabies: recent developments. Res Vet Sci 73:17-25.
  377. World Health Organization (WHO). 2005. WHO expert consultation on rabies. Database http://www.who.int/rabies/trs931_ 06_05.pdf.
  378. World Health Organization. 2008. Human and animal rabies. http://www.who.int/rabies/en/. Accessed 11/16/08.
  379. Wu X, Franka R, Svoboda P, et al. 2009. Development of combined vaccines for rabies and immunocontraception. Vaccine 27:7202-7209.
  380. Wu X, Hu R, Zhang Y, et al. 2009. Reemerging rabies and lack of systemic surveillance in People's Republic of China. Emerg Infect Dis 15:1159-1164.
  381. Wunderli PS, Dreesen DW, Miller TJ, et al. 2003. Effect of heterogenicity of rabies virus strain and challenge route on efficacy of inactivated rabies vaccines in mice. Am J Vet Res 64:499-505.
  382. Wunderli PS, Dreesen DW, Miller TJ, et al. 2003. Effects of vaccine route and dosage on protection from rabies after intracerebral challenge in mice. Am J Vet Res 64:491-498.
  383. Wunderli PS, Dreesen DW, Miller TJ, et al. 2006. The rabies peripheral challenge test: more accurate determination of vaccine potency. Vaccine 24:7115-7123.
  384. Wunner WH, Briggs DJ. 2010. Rabies in the 21st century. PLOS Negl Trop Dis 4:e591.
  385. Wyatt JD, Barker WH, Bennett NM, et al. 1999. Human rabies postexposure prophylaxis during a raccoon rabies epizootic in New York, 1993-1994. Emerg Infect Dis 5:415-423.
  386. Xuan X, Tuchiya K, Sato I, et al. 1998. Biological and immunogenic properties of rabies virus glycoprotein expressed by canine herpesvirus vector. Vaccine 16:969-976.
  387. Yakobson BA, King R, Sheichat N, et al. 2008. Assessment of the efficacy of oral vaccination of livestock guardian dogs in the framework of oral rabies vaccination of wild canids in Israel. Dev Biol (Basel) 131:151-156.
  388. Yarosh OK, Wandeler AI, Graham FL, et al. 1996. Human adenovirus type-5 vectors expressing rabies glycoprotein. Vaccine 14:1257-1264.
  389. Zhang S, Liu Y, Fooks AR, et al. 2008. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies. Vaccine 26:345-350.
  390. Zhang S, Liu Y, Zhang F, et al. 2009. Competitive ELISA using a rabies glycoprotein-transformed cell line to semi-quantify rabies neutralizing-related antibodies in dogs. Vaccine 27:2108-2113.
  391. Zhang YZ, Fu ZF, Wang DM, et al. 2008. Investigation of the role of healthy dogs as potential carriers of rabies virus. Vector Borne Zoonotic Dis 8:313-319.
  392. Zhu JH, Wang J, Cai B, et al. 1996. Immunogenicity and relative attenuation of different vaccinia-rabies virus recombinants. Arch Virol 141:1055-1065.
  393. Zinsstag J, Dürr S, Penny MA, et al. 2009. Transmission dynamics and economics of rabies control in dogs and humans in an African city. Proc Natl Acad Sci USA 106:14996-15001.
  394. Zulz GC, Sabeta CT, Nel LH. 2009. Molecular epidemiology of rabies: focus on domestic dogs (Canis familiaris) and black-backed jackals (Canis mesomelas) from northern South Africa. Vet Res 140:71-78.